Updated September 12, 2008

Premium Lock BioMerieux acquires California cancer-testing firm for $60M

Published: 2008-09-12 07:20:00
Updated: 2008-09-12 10:10:38

BioMerieux, a French life-sciences firm with its U.S. headquarters in Durham, is buying a California diagnostic-testing firm for $60 million.

AviaraDx, which is based in San Diego, has 19 employees and is privately held. It expects to report a loss of $8 million this year.

The California firm provides cancer tests that are designed to help oncologists make decisions in treatment strategies. It also operates a services lab.

As part of BioMerieux, AviaraDx will operate as BioTheranostics....

Read More
Read More

Copyright 2017 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Biotech & Life Science

Biotech & Life Science

The latest biotechnology and life science news. Read more articles…

Please Log In to add a comment.

Latest for Insiders